Inflammatory Myofibroblastic Tumour Clinical Trial
Official title:
Treatment With Crizotinib Single Patient Expanded Access IND 134375
Two year old male with a new diagnosis of Inflammatory Myofibroblastic Tumour. The patient
presented with 2 months of intermittent fever and 1-2 weeks of abdominal distention and
constipation. An abdominal mass was palpable on exam and US concerning was for neoplasm of
abdomen.
Treatment with Crizotinib will be utilized to reduce the size of the lesion and create more
optimal tissue plains between vital structures prior to attempted surgical resection would
greatly reduce potential morbidity for this patient.
n/a